Reaction

Congenital Nail Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 122 reports · 2 co-occurring drugs

As of the last recalculation, Congenital Nail Disorder appears in 122 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is EPOETIN ALFA (PRR 209.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoetin Alfa13209.4209.7
Misoprostol7130.0130.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.